References
- Silverberg E. Cancer statistics. American Cancer Society, New York 1977
- Julian C G., Woodruff J D. The role of chemotherapy in the treatment of primary ovarian malignancy. Obstet Gynecol Surv 1967; 24: 1307–42
- Greco F A., Julian C G., Richardson R L., Burnett L, Hande K R., Oldham R K. Advanced ovarian cancer: Brief intensive combination chemotherapy and second-look operation. Obstet Gynecol 1981; 58: 199–205
- Cohen C J., Goldberg J D., Holland J F., et al. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol 1983; 145: 955–67
- Day T G., Smith J P. Diagnosis and staging of ovarian carcinoma. Semin Oncol 1975; 2: 217–22
- Kottmeier H L. Ovarian cancer with special regard to radiotherapy. Gynecological Cancer, T J. Peeley. Appleton-Century-Crofts, New York 1971; 186–202
- Svanberg L, Åstedt B. Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors. Cancer 1975; 35: 1382–7
- Åstedt B, Tropé C. Effect of tranexamic acid on progress of experimental tumors and on DNA-synthesis. Experientia 1980; 36: 679–80
- Allan M S., Hertig A T. Carcinoma of the ovary. Am J Obstet Gynecol 1949; 58: 640–9
- Kikuchi Y, Takagi M, Parmley R T., Ghanta V K., Hiramoto R N. Inhibitory effect of L-homoarginine on murine osteosarcoma cell proliferation. Cancer Res 1982; 42: 1072–7
- Kikuchi Y, Momose E, Kizawa I, et al. Characterization of established cell line from human immature teratoma of the ovary and effects of retinoic acid on the cell proliferation. Cancer Res 1984; 44: 2952–8
- Åstedt B, Svanberg L, Nilsson I M.F.D.P. Lancet 1972; ii: 1312
- Soma H, Sashida T, Yoshida M, Miyashita T, Nakamura A. Treatment of advanced ovarian cancer with fibrinolytic inhibitor (tranexamic acid). Acta Obstet Gynecol Scand 1980; 59: 285–7
- Sigurdsson K, Johnsson J-E, Tropé C. Tranexamic acid for the treatment of advanced ovarian carcinoma. Acta Obstet Gynecol Scand 1983; 62: 265–6
- Bale W F., Spar I L., Goodland R L. (1962) Research directed toward the use of 131I-labelled fibrinogen and antibody to fibrin in the localization and treatment of tumors. Use of radioisotopes in animal biology and the medical sciences Conference Proc., Mexico City, 1961. 2: 271
- Åstedt B, Mattson W, Tropé C. Treatment of advanced breast cancer with chemotherapeutics and inhibition of coagulation and fibrinolysis. Acta Med Scand 1977; 201: 491–3